In a series of tumor samples comprised of 5 classified as basal-like, 6 classified as ERBB2-enriched and 16 classified as luminal [22], ACSL4 mRNA expression differed among the subtypes as follows: luminal, 317 ± 130, basal-like, 565 ± 128, and ERBB2-enriched, 364 ± 83. This evidence concerns the gene ACSL4 and neoplasm.